Embedded Files
The contents of this site are for private use only and are not to be distributed or
reproduced without the express written consent of the copyright holders.
2024 March - National Institutes of Health/National Cancer Institute - "Is ERBB4 a driver of BRAF-WT melanomas? - Diversity Supplement" - Application - Review
2023 February - National Institutes of Health/National Cancer Institute - "Is ERBB4 a driver of BRAF-WT melanomas?" - 1R15CA280767-01A1 - Application - Supplemental Information - Review - Notice of Award
2023 January - Auburn University Research Support Program - "Is EGFR or ERBB2 Required for ERBB4 to Drive the Proliferation of BRAF WT Metastatic Melanomas?" - Initial Review - Revised Application - Second-Tier Review - Not selected for funding
2022 June - National Institutes of Health/National Cancer Institute - "Is ERBB4 a driver of BRAF-WT melanomas" - 1R15CA280767-01 - Application - Supplemental Information - Review - Not selected for funding
2021 November - US Army Medical Research and Development Command CDMRP Melanoma Research Program - "Validation of the ERBB Signaling Network as a Target for Therapeutic Intervention in BRAF-WT Melanoma" - ME210378 - Application - Review - Initial Funding Decision - Final Funding Decision
2020 January - Auburn University Intramural Grant Program - "Targeted Melanoma Therapy: Identification of ERBB4 Melanoma Driver Mutants" - Application and Review (Zip file)
2019 October - US Army Medical Research and Development Command CDMRP Melanoma Research Program - "Identifying and Validating Metastatic Driver Mutations of ERBB4: Evaluating a Paradigm for Preventing and Targeting Metastatic Disease" - ME190139 - Application - Not selected for funding - Review
2018 February - National Institutes of Health/National Cancer Institute - "Preclinical cancer drug discovery training program" - F99CA234964 - Application - Not selected for funding - Review
2013 November - National Institutes of Health/National Cancer Institute - "Development of Assays for Chemotherapeutics Targeting the ErbB4 RTK" - R01CA175348 - Application - Not selected for funding
2013 September - US Army Medical Research and Materiel Command CDMRP Breast Cancer Research Program - "Exome Sequencing Breast Cancer Families From a Homogenous Population" - BC131426 - Not selected for funding
2012 July - National Science Foundation - 1250079 - "IGERT: Pharmaceutical Engineering" - Not selected for funding
2012 June - National Institutes of Health/National Cancer Institute - "Development of Screens for Probes and Chemotherapeutics That Target the ErbB4 RTK" - R01CA175348 - Application - Not selected for funding - Review
2012 January - US Department of Education Graduate Assistance in the Areas of National Need (GAANN) - "Fellowships in Biological and Pharmaceutical Engineering" - Selected for funding
2011 June - US Army Medical Research and Materiel Command CDMRP Breast Cancer Research Program - "Canine Breast Cancers as Models for Human Disease" - BC110547 - Application - Not selected for funding
2010 Oct - National Institutes of Health/National Cancer Institute - "Mapping Sites of Phosphorylation by ErbB Receptor Tyrosine Kinases" - R01CA161230 - Application - Not selected for funding - Review
2010 Oct - National Institutes of Health/National Cancer Institute - "Drug-sensitive EGF receptor mutants in lung cancer" - R01CA115830-06A1 - Application - Not selected for funding - Review
2010 May - Auburn University Internal Grants Program - "Validation of Canine Models for Human Breast Cancer" - Application - Selected for funding - Review
Report abuse